Single-agent anti-PD-1 balstilimab or in combination with anti-CTLA-4 zalifrelimab for recurrent/metastatic (R/M) cervical cancer (CC): Preliminary results of two independent phase II trials

D. M. O'Malley; A. Oaknin; B. J. Monk; A. Leary; F. Selle; J. Alexandre; L. M. Randall; C. Rojas; M. Neffa; A. Kryzhanivska; L. Gladieff; D. Berton; T. Meniawy; I. Lugowska; I. Bondarenko; K. N. Moore; W. I. Ortuzar Feliu; M. Ancukiewicz; I. Shapiro; I. L. Ray-Coquard

doi:10.1016/j.annonc.2020.08.2264

Single-agent anti-PD-1 balstilimab or in combination with anti-CTLA-4 zalifrelimab for recurrent/metastatic (R/M) cervical cancer (CC): Preliminary results of two independent phase II trials

D. M. O'Malley, A. Oaknin, B. J. Monk, A. Leary, F. Selle, J. Alexandre, L. M. Randall, C. Rojas, M. Neffa, A. Kryzhanivska, L. Gladieff, D. Berton, T. Meniawy, I. Lugowska, I. Bondarenko, K. N. Moore, W. I. Ortuzar Feliu, M. Ancukiewicz, I. Shapiro, I. L. Ray-Coquard

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

29 Citations (Web of Science)

Original language	English
Pages (from-to)	S1164-S1165
Number of pages	2
Journal	Annals of Oncology
Volume	31
DOIs	https://doi.org/10.1016/j.annonc.2020.08.2264
Publication status	Published - Sept 2020
Event	ESMO Virtual Congress 2020 - , Virtual Duration: 19 Sept 2020 → 21 Sept 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.annonc.2020.08.2264

Cite this

O'Malley, D. M., Oaknin, A., Monk, B. J., Leary, A., Selle, F., Alexandre, J., Randall, L. M., Rojas, C., Neffa, M., Kryzhanivska, A., Gladieff, L., Berton, D., Meniawy, T., Lugowska, I., Bondarenko, I., Moore, K. N., Feliu, W. I. O., Ancukiewicz, M., Shapiro, I., & Ray-Coquard, I. L. (2020). Single-agent anti-PD-1 balstilimab or in combination with anti-CTLA-4 zalifrelimab for recurrent/metastatic (R/M) cervical cancer (CC): Preliminary results of two independent phase II trials. Annals of Oncology, 31, S1164-S1165. https://doi.org/10.1016/j.annonc.2020.08.2264

@article{de039cf9b8b142eebe957aa6e5ad4efe,

title = "Single-agent anti-PD-1 balstilimab or in combination with anti-CTLA-4 zalifrelimab for recurrent/metastatic (R/M) cervical cancer (CC): Preliminary results of two independent phase II trials",

author = "O'Malley, {D. M.} and A. Oaknin and Monk, {B. J.} and A. Leary and F. Selle and J. Alexandre and Randall, {L. M.} and C. Rojas and M. Neffa and A. Kryzhanivska and L. Gladieff and D. Berton and T. Meniawy and I. Lugowska and I. Bondarenko and Moore, {K. N.} and Feliu, {W. I. Ortuzar} and M. Ancukiewicz and I. Shapiro and Ray-Coquard, {I. L.}",

year = "2020",

month = sep,

doi = "10.1016/j.annonc.2020.08.2264",

language = "English",

volume = "31",

pages = "S1164--S1165",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

note = "ESMO Virtual Congress 2020 ; Conference date: 19-09-2020 Through 21-09-2020",

}

O'Malley, DM, Oaknin, A, Monk, BJ, Leary, A, Selle, F, Alexandre, J, Randall, LM, Rojas, C, Neffa, M, Kryzhanivska, A, Gladieff, L, Berton, D, Meniawy, T, Lugowska, I, Bondarenko, I, Moore, KN, Feliu, WIO, Ancukiewicz, M, Shapiro, I & Ray-Coquard, IL 2020, 'Single-agent anti-PD-1 balstilimab or in combination with anti-CTLA-4 zalifrelimab for recurrent/metastatic (R/M) cervical cancer (CC): Preliminary results of two independent phase II trials', Annals of Oncology, vol. 31, pp. S1164-S1165. https://doi.org/10.1016/j.annonc.2020.08.2264

Single-agent anti-PD-1 balstilimab or in combination with anti-CTLA-4 zalifrelimab for recurrent/metastatic (R/M) cervical cancer (CC): Preliminary results of two independent phase II trials. / O'Malley, D. M.; Oaknin, A.; Monk, B. J. et al.
In: Annals of Oncology, Vol. 31, 09.2020, p. S1164-S1165.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - Single-agent anti-PD-1 balstilimab or in combination with anti-CTLA-4 zalifrelimab for recurrent/metastatic (R/M) cervical cancer (CC)

T2 - ESMO Virtual Congress 2020

AU - O'Malley, D. M.

AU - Oaknin, A.

AU - Monk, B. J.

AU - Leary, A.

AU - Selle, F.

AU - Alexandre, J.

AU - Randall, L. M.

AU - Rojas, C.

AU - Neffa, M.

AU - Kryzhanivska, A.

AU - Gladieff, L.

AU - Berton, D.

AU - Meniawy, T.

AU - Lugowska, I.

AU - Bondarenko, I.

AU - Moore, K. N.

AU - Feliu, W. I. Ortuzar

AU - Ancukiewicz, M.

AU - Shapiro, I.

AU - Ray-Coquard, I. L.

PY - 2020/9

Y1 - 2020/9

U2 - 10.1016/j.annonc.2020.08.2264

DO - 10.1016/j.annonc.2020.08.2264

M3 - Abstract/Meeting Abstract

SN - 0923-7534

VL - 31

SP - S1164-S1165

JO - Annals of Oncology

JF - Annals of Oncology

Y2 - 19 September 2020 through 21 September 2020

ER -